Free Trial
NASDAQ:AVR

Anteris Technologies Global Q2 2025 TU Earnings Report

Anteris Technologies Global logo
$3.92 -0.14 (-3.45%)
As of 08/14/2025 04:00 PM Eastern

Anteris Technologies Global EPS Results

Actual EPS
-$0.58
Consensus EPS
-$0.53
Beat/Miss
Missed by -$0.05
One Year Ago EPS
N/A

Anteris Technologies Global Revenue Results

Actual Revenue
$0.62 million
Expected Revenue
$0.58 million
Beat/Miss
Beat by +$38.00 thousand
YoY Revenue Growth
N/A

Anteris Technologies Global Announcement Details

Quarter
Q2 2025 TU
Time
Before Market Opens
Conference Call Date
Monday, August 11, 2025
Conference Call Time
6:00PM ET

Earnings Documents

Anteris Technologies Global Earnings Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Anteris Announces Results for the Second Quarter of 2025
See More Anteris Technologies Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Anteris Technologies Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anteris Technologies Global and other key companies, straight to your email.

About Anteris Technologies Global

Anteris Technologies Global (NASDAQ:AVR) engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

View Anteris Technologies Global Profile

More Earnings Resources from MarketBeat